1. Establishing the benefit of statins in low-to-moderate—risk primary prevention: The Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) 
A.M. Gotto Jr. 
Atherosclerosis Supplements 
Volume 8, Issue 2, Pages 3-8 (August 2007)
DOI: /j.atherosclerosissup
Copyright © Terms and Conditions

2. Fig. 1
Baseline lipids parameters in AFCAPS/TexCAPS, Lipids Research Clinics (LRC-CCP), Helsinki Heart Study (HHS), and WOSCOPS.
Atherosclerosis Supplements 2007 8, 3-8DOI: ( /j.atherosclerosissup )
Copyright © Terms and Conditions

3. Fig. 2
AFCAPS/TexCAPS: percent changes of lipids parameters from baseline to year 1. Reproduced with permission from ref. [1].
Atherosclerosis Supplements 2007 8, 3-8DOI: ( /j.atherosclerosissup )
Copyright © Terms and Conditions

4. Fig. 3
AFCAPS/TexCAPS: first acute major coronary event. Adapted with permission from ref. [1].
Atherosclerosis Supplements 2007 8, 3-8DOI: ( /j.atherosclerosissup )
Copyright © Terms and Conditions

5. Fig. 4
Secondary endpoint analyses. Adapted with permission from ref. [1].
Atherosclerosis Supplements 2007 8, 3-8DOI: ( /j.atherosclerosissup )
Copyright © Terms and Conditions

6. Fig. 5
Relation of acute major coronary events with baseline and year 1 LDL-C and ApoB adjusted for age, sex, marital status, hypertension, smoking, and family history. Adapted with permission from ref. [5].
Atherosclerosis Supplements 2007 8, 3-8DOI: ( /j.atherosclerosissup )
Copyright © Terms and Conditions